InVivoPlus anti-mouse GITR

Catalog number: BP0063_100mg
Brand: Bio X Cell
Packing: 100 mg
Other sizes: 5 mg
25 mg
50 mg
Price: € 3350.00
Expected delivery time: 7 days
Quantity:

Product specifications for - InVivoPlus anti-mouse GITR

Promotion: 
Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: Other Application
Species: Mouse
Host: Rat
Clonality: Monoclonal
Isotype: IgG2b Lambda
Properties: 
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: DTA-1
Related products: 
Related products: Recommended Isotype Control(s): InVivoPlus rat IgG2b I sotype control (BP0090)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: DTA-1; BP0063; BioXCell
Bartkowiak T, Singh S, Yang G, et al. Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine. Proc Natl Acad Sci USA. 2015;112(38):E5290-9. Read more
Lu L, Xu X, Zhang B, Zhang R, Ji H, Wang X. Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs. J Transl Med. 2014;12:36. Read more
Bulliard Y, Jolicoeur R, Windman M, et al. Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. J Exp Med. 2013;210(9):1685-93. Read more
Côté AL, Zhang P, O'sullivan JA, et al. Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens. J Immunol. 2011;186(1):275-83. Read more
Johanns TM, Ertelt JM, Rowe JH, Way SS. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog. 2010;6(8):e1001043. Read more